Table III.
Association between protocadherin 8 methylation and pathological features of patients with prostate cancer.
| Feature | Total, n | Unmethylated, n (%) | Methylated, n (%) | χ2 value | P-value |
|---|---|---|---|---|---|
| Age, years | 0.040 | 0.842 | |||
| ≤65 | 50 | 27 (54.00) | 23 (46.00) | ||
| >65 | 32 | 18 (56.25) | 14 (43.75) | ||
| Tumor number | 0.455 | 0.500 | |||
| Single | 34 | 16 (47.06) | 18 (52.94) | ||
| Multiple | 48 | 19 (39.58) | 29 (60.42) | ||
| Tumor diameter | 5.828 | 0.016 | |||
| ≤3 cm | 46 | 25 (54.35) | 21 (45.65) | ||
| >3 cm | 36 | 10 (27.78) | 26 (72.22) | ||
| Tumor shape | 5.131 | 0.023 | |||
| Papillary | 57 | 29 (50.88) | 28 (49.12) | ||
| Non-papillary | 25 | 6 (24.00) | 19 (76.00) | ||
| Tumor stage | 5.803 | 0.016 | |||
| Ta-T1 | 51 | 27 (52.94) | 24 (47.06) | ||
| T2-T4 | 31 | 8 (25.81) | 23 (74.19) | ||
| Pathological grade | 6.888 | 0.009 | |||
| G1-G2 | 55 | 29 (52.73) | 26 (47.27) | ||
| G3 | 27 | 6 (22.22) | 21 (77.78) |